Data / Form D filings / EnZeta Immunotherapies, Inc.
EnZeta Immunotherapies, Inc.: Form D filings
EnZeta Immunotherapies, Inc., a biotechnology company in Coral Gables, FL, filed 4 Form D notices with the SEC between 2023 and 2026. The latest, on March 6, 2026, reports $840,000 sold of a $2.4 million offering to 10 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 122 SEVILLA AVE # 919, Coral Gables, FL, 33134
- Phone
- (917) 364-4613
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2023
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1994145
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 6, 2026 | Amendment | $2,370,000 | $840,000 | $1,530,000 | 10 | Feb 17, 2025 | sec.gov |
| Feb 20, 2025 | New notice | $1,000,000 | $200,000 | $800,000 | 3 | Feb 17, 2025 | sec.gov |
| Sep 29, 2023 | New notice | $5,000 | $5,000 | 5 | Sep 14, 2023 | sec.gov | |
| Sep 26, 2023 | New notice | $10,000 | $10,000 | 2 | Sep 8, 2023 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Paul Kelly | Executive Officer, Director | |
| Sergio Traversa | Director |
Other biotechnology companies in Florida that filed recently
- AdhereBio LLC offering · Oct 26, 2026
- Ascoltare Holdings LLC $1.7 million · Oct 23, 2026
- Immorta Bio, Inc. $612,503 · Oct 16, 2026
- CURADEL SURGICAL INNOVATIONS, INC. $49.8 million · Oct 13, 2026
- BioStem Technologies, Inc. $3 million · Oct 9, 2026
- HCW Biologics Inc. $1.5 million · Oct 8, 2026
Every Form D from the week of Mar 2, 2026 · All recent filings in Florida · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what EnZeta Immunotherapies, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.